Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 96,699
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12599666 | Photolytic compounds and triplet-triplet annihilation mediated photolysis | 🖼🧊📄§ | 2026-04-14 | 2040-10-07 | 0 | 31 |
| 12600986 | Nucleic acid molecules containing spacers and methods of use thereof | 🖼🧊📄§ | 2026-04-14 | 2042-01-21 | 0 | 31 |
| 12599574 | Process of making membrane lipid coated nanoparticles | 🖼🧊📄§ | 2026-04-14 | 2040-07-16 | 0 | 31 |
| 12599604 | Application of JAK inhibitor in kidney disease | 🖼🧊📄§ | 2026-04-14 | 2041-12-10 | 0 | 31 |
| 12600772 | Therapeutic agent for asthma containing IL-6 inhibitor | 🖼🧊📄§ | 2026-04-14 | 2039-01-31 | 0 | 31 |
| 12600765 | Target for anti-cancer and immune-enhancing | 🖼🧊📄§ | 2026-04-14 | 2041-04-09 | 0 | 31 |
| 12600781 | Tumor-targeted agonistic CD28 antigen binding molecules | 🖼🧊📄§ | 2026-04-14 | 2042-11-17 | 0 | 31 |
| 12600780 | Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2043-11-17 | 0 | 31 |
| 12600776 | Anti-L1CAM antibody or antigen-binding fragment thereof and chimeric antigen receptor comprising same | 🖼🧊📄§ | 2026-04-14 | 2039-10-21 | 0 | 31 |
| 12600785 | Method of screening for compounds that inhibit proliferation of pancreatic cancer cells having a loss-of-function mutation in the RNF43 gene | 🖼🧊📄§ | 2026-04-14 | 2041-02-15 | 0 | 31 |
| 12600784 | Anti-Clec12A antibodies and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2042-04-25 | 0 | 31 |
| 12600787 | Methods for the treatment of thyroid eye disease | 🖼🧊📄§ | 2026-04-14 | 2042-03-10 | 0 | 31 |
| 12600788 | Compositions and methods for treatment of thyroid eye disease | 🖼🧊📄§ | 2026-04-14 | 2045-06-18 | 0 | 31 |
| 12600792 | Monoclonal antibodies and methods of use | 🖼🧊📄§ | 2026-04-14 | 2042-03-24 | 0 | 31 |
| 12600821 | Crosslinked organosilicon resin, a method for producing same, and a cosmetic | 🖼🧊📄§ | 2026-04-14 | 2044-01-19 | 0 | 31 |
| 12600819 | Composition for fast-cured thermosets containing amines, thiols and unsaturated molecules | 🖼🧊📄§ | 2026-04-14 | 2040-12-16 | 0 | 31 |
| 12600946 | Method for increasing dendritic cell migration ability, and use thereof | 🖼🧊📄§ | 2026-04-14 | 2039-01-28 | 0 | 31 |
| 12600949 | Modified macrophages, compositions and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2041-04-19 | 0 | 31 |
| 12600762 | Masked cytokines and methods of use thereof | 🖼🧊📄§ | 2026-04-14 | 2041-01-11 | 0 | 31 |
| 12600763 | Compositions and methods for the delivery of therapeutic biologics for treatment of disease | 🖼🧊📄§ | 2026-04-14 | 2042-08-08 | 0 | 31 |
| 12600752 | Methods and compositions for recombinant dengue viruses or vaccine and diagnostic development | 🖼🧊📄§ | 2026-04-14 | 2040-11-20 | 0 | 31 |
| 12600749 | Compstatin analogues and their medical uses | 🖼🧊📄§ | 2026-04-14 | 2044-03-11 | 0 | 31 |
| 12600758 | Interleukin-2 muteins for the expansion of T-regulatory cells | 🖼🧊📄§ | 2026-04-14 | 2040-08-13 | 0 | 31 |
| 12600708 | Prodrug compounds of 3,4-methylenedioxymethamphetamine (MDMA) and methods of synthesizing the same | 🖼🧊📄§ | 2026-04-14 | 2043-07-26 | 0 | 31 |
| 12600721 | TYK2 inhibitors and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2042-02-16 | 0 | 31 |
| 12600728 | Interleukin-17 inhibitors | 🖼🧊📄§ | 2026-04-14 | 2041-11-01 | 0 | 31 |
| 12600727 | Treatment of infections of toxoplasma gondii and closely related parasites | 🖼🧊📄§ | 2026-04-14 | 2039-09-18 | 0 | 31 |
| 12600738 | Quinolinone derivative compound selectively binding to cysteine, peptide conjugate thereof, and antibody-drug conjugate comprising same | 🖼🧊📄§ | 2026-04-14 | 2041-08-25 | 0 | 31 |
| 12599560 | Lipids and lipid nanoparticle formulations | 🖼🧊📄§ | 2026-04-14 | 2043-12-07 | 0 | 31 |
| 12599623 | Skin compositions and methods of use thereof | 🖼🧊📄§ | 2026-04-14 | 2037-06-29 | 0 | 31 |
| 12599632 | Therapeutic agent for nerve disorders | 🖼🧊📄§ | 2026-04-14 | 2041-11-30 | 0 | 31 |
| 12599631 | Agent for treating or preventing vascular dementia | 🖼🧊📄§ | 2026-04-14 | 2040-08-07 | 0 | 31 |
| 12599633 | Mesenchymal stem cells for use in the treatment of skin defects | 🖼🧊📄§ | 2026-04-14 | 2042-05-20 | 0 | 31 |
| 12599636 | Treatment of Krabbe disease with umbilical cord blood transplantion (UCBT) and increased galactocerebrosidase (GALC) expression | 🖼🧊📄§ | 2026-04-14 | 2038-01-19 | 0 | 31 |
| 12599637 | Genetically modified Lactobacillus and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-02-04 | 0 | 31 |
| 12599641 | Probiotic composition for improving soy protein proteolysis and amino acid production activity | 🖼🧊📄§ | 2026-04-14 | 2044-05-28 | 0 | 31 |
| 12599642 | Compositions derived from Salvia hispanica seeds | 🖼🧊📄§ | 2026-04-14 | 2041-03-04 | 0 | 31 |
| 12599643 | Use of green coffee based compositions for improving insulin profile | 🖼🧊📄§ | 2026-04-14 | 2040-03-27 | 0 | 31 |
| 12599647 | Peptide amide composition and preparation method therefor | 🖼🧊📄§ | 2026-04-14 | 2040-08-24 | 0 | 31 |
| 12599646 | Peptide-containing composition for use for treating neoplastic lesions | 🖼🧊📄§ | 2026-04-14 | 2040-03-10 | 0 | 31 |
| 12599644 | Treatment of coronavirus infection with Flt3 receptor interacting lectin (FRIL) | 🖼🧊📄§ | 2026-04-14 | 2041-05-06 | 0 | 31 |
| 12599652 | Serum albumin-binding fibronectin type III domains | 🖼🧊📄§ | 2026-04-14 | 2043-10-27 | 0 | 31 |
| 12599650 | Inhibition of SIRP-gamma for cancer treatment | 🖼🧊📄§ | 2026-04-14 | 2040-06-23 | 0 | 31 |
| 12599653 | Thrombolytic agents for intravascular clots | 🖼🧊📄§ | 2026-04-14 | 2040-10-19 | 0 | 31 |
| 12599657 | Enhancement of vaccine efficacy via biomass and/or related material in animal drink and feed | 🖼🧊📄§ | 2026-04-14 | 2041-07-02 | 0 | 31 |
| 12599656 | Methods for treating HPV-associated diseases | 🖼🧊📄§ | 2026-04-14 | 2039-03-11 | 0 | 31 |
| 12599660 | Therapeutic RNA for HPV-positive cancer | 🖼🧊📄§ | 2026-04-14 | 2041-07-06 | 0 | 31 |
| 12599665 | Gene fusions for control of genetically modified cells | 🖼🧊📄§ | 2026-04-14 | 2041-08-12 | 0 | 31 |
| 12599668 | Antibodies | 🖼🧊📄§ | 2026-04-14 | 2040-02-20 | 0 | 31 |
| 12599663 | Multivalent peptide conjugates for sustained intra-articular treatment of joint inflammation | 🖼🧊📄§ | 2026-04-14 | 2039-03-08 | 0 | 31 |